Yiru Long

Years Active: 2022-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaolu Yu, Yiru Long, Binfan Chen, Yongliang Tong, Mengwen Shan, Xiaomin Jia, Chao Hu, Meng Liu, Ji Zhou, Feng Tang, Henglei Lu, Runqiu Chen, Pan Xu, Wei Huang, Jin Ren, Yakun Wan, Jianhua Sun, Jia Li, Guangyi Jin, Likun Gong
PD-L1/TLR7 dual-targeting nanobody-drug conjugate mediates potent tumor regression via elevating tumor immunogenicity in a host-expressed PD-L1 bias-dependent way. Journal for immunotherapy of cancer 10 (10) (2022)
Yiru Long, Runqiu Chen, Xiaolu Yu, Yongliang Tong, Xionghua Peng, Fanglin Li, Chao Hu, Jianhua Sun, Likun Gong
Suppression of tumor or host intrinsic CMTM6 drives antitumor cytotoxicity in a PD-L1 independent manner. Cancer immunology research (2022)
Yiru Long, Jianhua Sun, Tian-Zhang Song, Tingting Liu, Feng Tang, Xinxin Zhang, Longfei Ding, Yunqiu Miao, Jianming Zhu, Xiaoyan Pan, Qi An, Mian Qin, Xiankun Tong, Xionghua Peng, Pan Yu, Peng Zhu, Jianqing Xu, Xiaoyan Zhang, Yachun Zhang, Datao Liu, Ben Chen, Huilin Chen, Lei-Ke Zhang, Gengfu Xiao, Jianping Zuo, Wei Tang, Ji Zhou, Heng Li, Zhijian Xu, Hong-Yi Zheng, Xin-Yan Long, Qiuping Qin, Yong Gan, Jin Ren, Wei Huang, Yong-Tang Zheng, Guangyi Jin, Likun Gong
CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity. Cell discovery 8 (1) (2022)

Yiru Long.css-eqlu8i{font-size:small;padding-left:4px;}